Pharmaceutical | Tokio X'press - Part 31

COVID-19：ロシュの関節炎治療薬トシリズマブ：死亡リスクを軽減（動画）：　 RECOVERY Data Shows Roche Tocilizumab Cuts Deaths in COVID-19 Patients: 恢复试验数据表明罗氏关节炎药物可减少住院的COVID-19患者的死亡

2021年02月22日By Tokio X'press flu, Health & Safety, Product Safety & Quality, Access to Health Care, Pharmaceutical

COVID-19：イベルメクチン､ランダム化二重盲検治験：イスラエルSheba（動画）：　 Randomized Double-Blinded Trial at Sheba Medical Center:Ivermectin：　舍巴医学中心的随机双盲临床试验：伊维菌素可从本质上降低COVID-19

2021年02月18日By Tokio X'press flu, Product Safety & Quality, Insuring Health & Demographic Risk, Opportunities in Nutrition & Health, Business Ethics, Pharmaceutical

大阪大：ｉＰＳで目の結膜細胞作製：ドライアイの創薬に期待（動画）：　 Osaka Univ: Making eye conjunctival cells with iPS: for drug of dry eye: 大阪大学：使用iPS制作眼结膜细胞：对干眼症药物发现的期望

2021年02月15日By Tokio X'press Health & Safety, 1.Product Liability, Product Safety & Quality, Access to Health Care, Opportunities in Nutrition & Health, IPS, Medical science, Pharmaceutical

COVID-19： Appili､米国でファビピラビル治験：第3相試験募集（動画）：　 Appili Provides Enrollment Update for Phase 3 PRESECO Trial Favipiravir：　 Appili Therapeutics提供了其PRESECO第三阶段试验的注册更新

2021年02月12日By Tokio X'press flu, 1.Human Capital, Health & Safety, 1.Product Liability, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Drugs, Pharmaceutical

岩手大：’カイコ冬虫夏草’物質が寄与：認知症やアルツハイマー病（動画）：　 Iwate Univ: ‘Cacerpillar fungus’ substance: dementia､Alzheimer’s disease: 岩手大学：“毛虫真菌”物质的贡献：痴呆症和阿尔茨海默氏病

2021年02月09日By Tokio X'press Alzheimer, 0.Env.Opportunities, 1.Human Capital, Health & Safety, Access to Health Care, Opportunities in Nutrition & Health, Pharmaceutical

1 … 30 31 32 … 111